SPECIAL ISSUE SIRACUSA 23TH OCTOBER, CURED AND CHRONIC: WHERE WE ARE
R. De Angelis, E. Demuru, L. Dal Maso, S. Rossi
Vol.7 issue 4 (2024), pag. 120 - 147
| Received | 26/10/2024 |
| Accepted | 26/10/2024 |
| Published | 19/12/2024 |
ABSTRACT
Complete prevalence – including all people living with and beyond a cancer – relies on population-based cancer registries (CRs) data and on specific statistical methods to compensate the limited follow-up observations. The latest cancer prevalence estimates allow to quantify and characterise cancer survivors by sex, cancer type, age, disease duration and country in Europe 2020.